LivaNova PLC Ordinary Shares (LIVN) — 分析摘要
LivaNova PLC Ordinary Shares（LIVN）的市值为4.56十亿美元，最近一年的营收同比增长了+10.7%。净利润率为-17.5%。当前市盈率为42.5倍。
核心要点
- 营收同比变化+10.7%
- 净利润率-17.5%
- 市盈率42.5倍
与ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS板块的其他公司相比，LIVN的营收增长为+10.7%，市盈率为42.5倍。
LivaNova PLC Ordinary Shares (LIVN)
更新 — ET · 来源 POLYGON
红旗与风险提示无重大红旗
基于最新财报，没有触发重大的信用、利润率或趋势红旗。
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.
行业
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
员工人数
3,300
总部
LONDON, X0
Exchange
XNAS
基于 4 年财务数据的系统性竞争优势评估
此评估基于历史财务数据的量化分析，不构成投资建议。护城河评级可能随行业和竞争环境变化。
首版展示近期 SEC Forms 3、4、5 备案活动。尚未解析单笔买入/卖出交易。
资本结构
现金流
免责声明：本站内容不构成投资建议。数据来源于SEC EDGAR和Polygon.io。过往业绩不代表未来表现。投资决策前请自行研究。